Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of IDP-115 in Rosacea
NCT00667173Phase 2Completed
- Sponsor
- Dow Pharmaceutical Sciences
- Start
- Nov 2007
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of IDP-115 in rosacea, sponsored by Dow Pharmaceutical Sciences. Started Nov 2007; status: completed.
02
Drugs
IDP-115
03
Conditions
rosacea
Beyond the preview
Go deeper on NCT00667173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00667173.